Page last updated: 2024-10-22

amiodarone and Fuchs' Endothelial Dystrophy

amiodarone has been researched along with Fuchs' Endothelial Dystrophy in 1 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Fuchs' Endothelial Dystrophy: Disorder caused by loss of endothelium of the central cornea. It is characterized by hyaline endothelial outgrowths on Descemet's membrane, epithelial blisters, reduced vision, and pain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davitt, SP1
Mannis, MJ1

Other Studies

1 other study available for amiodarone and Fuchs' Endothelial Dystrophy

ArticleYear
Delayed development of amiodarone keratopathy in a corneal graft.
    Cornea, 1997, Volume: 16, Issue:6

    Topics: Aged; Amiodarone; Angina Pectoris; Cataract Extraction; Cornea; Corneal Diseases; Follow-Up Studies;

1997